Back to Trials
NCT06583408Recruiting

The REgistry of Very Early Estrogen and AnovuLation

Mayo Clinic

Start Date

7/1/2024

Completion Date

8/1/2029

Summary

The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.

Eligibility Criteria

Age Range: 18 years to 40 years

Inclusion Criteria: * 3 or more months of consecutive amenorrhea with a diagnosis of functional hypothalamic amenorrhea or screening hormones consistent with functional hypothalamic amenorrhea including but not limited to: * Estradiol: \< 50pg/mL * LH: \< 10 IU/mL * FSH: \< 10 IU * Testosterone: 2 - 45 ng/dL * Free Testosterone: 0.1 - 6.4 pg/mL * FT4: 0.93 - 1.70 ng/dL * Prolactin: \< 20 ng/mL * AMH: \> 1 ng/mL * Urine or serum human chorionic gonadotropin: Negative * LH:FSH Ratio \<1 * No signs of male-like hair growth on the upper lip, chin, chest, abdomen, buttocks, or back * Does not have a diagnosis for secondary amenorrhea, including prolactinoma, PCOS, premature ovarian insufficiency, pituitary surgery, infection, or infarction * Premenopausal status determined by WISE criteria * Able to give informed consent * Able to read English Exclusion Criteria: * Parturition/lactating in the last 6-12 months * Lack of consent

Interventions

OTHER

Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24)

OTHER

REVEAL Questionnaire

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Hypothalamic Amenorrhea, FunctionalHypothalamic AmenorrheaFunctional Hypogonadotropic Hypogonadism

Locations

Mayo Clinic

Jacksonville, Florida 32224

United States

Mayo Clinic

Rochester, Minnesota 55905

United States